RA CAPITAL MANAGEMENT, L.P. reported 1 transaction at INHIBIKASE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/31/2026ACC: 0001231919-26-000815
10% Owner
Since Jul 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18.03M acquired · 18.03M disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−18.03M
Price / share
—
Trade value
—
% of position
72.1%
7/29/2026
25M→6.97M
Total
Net shares
−18.03M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/29/2026 | J · J | −18.03M | — | — | 72.1% | 25M | 6.97M |
| Total | −18.03M | $0.00 | ||||||
Derivative Transactions1
Pre-Funded Warrant (Right to Buy)
Indirect
Converts to
Common Stock
18.03M shares
Shares
+18.03M
Strike price
0.001
Held after
18.03M
Exercisable
—
7/29/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Pre-Funded Warrant (Right to Buy) Indirect | Common Stock18.03M shares | 7/29/2026 | J · J | +18.03M | 0.001 | — | 18.03M |